CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Junik

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 7 EU WC, 2 KDMF, 15 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

FINISHED DOSAGE FORMULATIONS

309 FDF Dossiers, 16 FDA Orange Book, 220 Europe, 7 Canada, 16 Australia, 15 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 17 Thickeners and Stabilizers, 15 Solubilizers, 9 Parenteral, 9 Direct Compression, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 5 Granulation, 5 Controlled & Modified Release, 4 Film Formers & Plasticizers, 4 Chewable & Orodispersible Aids, 4 Coating Systems & Additives, 3 Taste Masking, 3 Surfactant & Foaming Agents, 3 Topical, 3 Emulsifying Agents, 1 API Stability Enhancers, 1 Lubricants & Glidants

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 19 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 70 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

44 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
30/12/2025	Axplora	Germany	Farmabios S.p.A.	46439-8714	BECLOMETHASONE DIPROPIONATE	1993-06-18	2026-12-31	BULK INGREDIENT	POWDER (1g/g)
30/12/2025	Axplora	Germany	Farmabios S.p.A.	46439-8748	BECLOMETHASONE DIPROPIONATE MONOHYDRATE	2000-10-09	2026-12-31	BULK INGREDIENT	POWDER (1g/g)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Junik

Junik

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers

18 USDMF

12 CEP/COS

2 JDMF

7 EU WC

2 KDMF

15 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

FINISHED DOSAGE FORMULATIONS

309 FDF Dossiers

16 FDA Orange Book

220 Europe

7 Canada

16 Australia

15 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 DKSH

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Kirsch Pharma

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures

2 Kerry

2 Keval Exports

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 Silverline Chemicals

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

17 Thickeners and Stabilizers

15 Solubilizers

9 Parenteral

9 Direct Compression

8 Co-Processed Excipients

6 Rheology Modifiers

5 Disintegrants & Superdisintegrants

5 Granulation

5 Controlled & Modified Release

4 Film Formers & Plasticizers

4 Chewable & Orodispersible Aids

4 Coating Systems & Additives

3 Taste Masking

3 Surfactant & Foaming Agents

3 Topical

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons